Sabra Healthcare REIT (NASDAQ:SBRA) Coverage Initiated by Analysts at UBS Group

UBS Group initiated coverage on shares of Sabra Healthcare REIT (NASDAQ:SBRA) in a research report released on Tuesday, Marketbeat.com reports. The firm issued a neutral rating and a $20.00 price target on the real estate investment trust’s stock.

Other equities analysts have also issued reports about the company. JMP Securities upped their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “market outperform” rating in a research note on Wednesday, August 6th. BMO Capital Markets upped their price objective on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a “market perform” rating in a research report on Monday, August 25th. Wells Fargo & Company dropped their target price on shares of Sabra Healthcare REIT from $21.00 to $20.00 and set an “overweight” rating for the company in a research report on Tuesday, October 21st. Wall Street Zen cut shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $20.67.

Sabra Healthcare REIT Stock Performance

NASDAQ SBRA opened at $18.81 on Tuesday. Sabra Healthcare REIT has a 1 year low of $15.60 and a 1 year high of $19.97. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. The stock has a market capitalization of $4.69 billion, a PE ratio of 24.75, a P/E/G ratio of 1.10 and a beta of 0.84. The company’s 50 day simple moving average is $18.37 and its two-hundred day simple moving average is $18.33.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.01. The firm had revenue of $190.04 million during the quarter, compared to analyst estimates of $193.44 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. Analysts predict that Sabra Healthcare REIT will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 28th. Stockholders of record on Monday, November 17th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Monday, November 17th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.4%. Sabra Healthcare REIT’s dividend payout ratio is 166.67%.

Hedge Funds Weigh In On Sabra Healthcare REIT

Large investors have recently added to or reduced their stakes in the business. Larson Financial Group LLC grew its position in Sabra Healthcare REIT by 42.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 553 shares during the period. Anchor Investment Management LLC lifted its holdings in shares of Sabra Healthcare REIT by 15.5% during the 3rd quarter. Anchor Investment Management LLC now owns 4,150 shares of the real estate investment trust’s stock valued at $77,000 after buying an additional 556 shares during the period. Oppenheimer & Co. Inc. grew its holdings in shares of Sabra Healthcare REIT by 1.7% in the third quarter. Oppenheimer & Co. Inc. now owns 33,984 shares of the real estate investment trust’s stock worth $633,000 after acquiring an additional 581 shares during the period. Journey Strategic Wealth LLC increased its position in Sabra Healthcare REIT by 3.3% during the third quarter. Journey Strategic Wealth LLC now owns 18,479 shares of the real estate investment trust’s stock valued at $344,000 after acquiring an additional 595 shares during the last quarter. Finally, Natixis Advisors LLC increased its position in Sabra Healthcare REIT by 2.2% during the third quarter. Natixis Advisors LLC now owns 27,664 shares of the real estate investment trust’s stock valued at $516,000 after acquiring an additional 598 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.